Search Results

There are 13809 results for: content related to: Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study

  1. You have free access to this content
    Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?

    Transplant International

    Volume 24, Issue 6, June 2011, Pages: 570–581, Guy N. Brock, Farida Mostajabi, Nicole Ferguson, Christopher J. Carrubba, Mary Eng, Joseph F. Buell and Michael R. Marvin

    Version of Record online : 15 MAR 2011, DOI: 10.1111/j.1432-2277.2011.01236.x

  2. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation

    Intervention Review

    The Cochrane Library

    Lior H Katz, Ran Tur-Kaspa, Daniel G Guy and Mical Paul

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD006005.pub2

  3. You have free access to this content
    High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review

    American Journal of Transplantation

    Volume 13, Issue 2, February 2013, Pages: 353–362, E. Cholongitas and G.V. Papatheodoridis

    Version of Record online : 8 NOV 2012, DOI: 10.1111/j.1600-6143.2012.04315.x

  4. Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: A systematic review

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 872–879, Jie Chen, Liping Yi, Ji Dong Jia, Hong Ma and Hong You

    Version of Record online : 29 OCT 2009, DOI: 10.1111/j.1440-1746.2009.06151.x

  5. You have full text access to this OnlineOpen article
    Safe and cost-effective control of post-transplantation recurrence of hepatitis B

    Hepatology Research

    Volume 45, Issue 1, January 2015, Pages: 38–47, Akinobu Takaki, Takahito Yagi and Kazuhide Yamamoto

    Version of Record online : 18 JUL 2014, DOI: 10.1111/hepr.12368

  6. You have free access to this content
    Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective

    Liver Transplantation

    Volume 11, Issue 7, July 2005, Pages: 716–732, Norah Terrault, Bruno Roche and Didier Samuel

    Version of Record online : 22 JUN 2005, DOI: 10.1002/lt.20492

  7. You have free access to this content
    Posttransplantation Hepatitis B Prophylaxis with Combination Oral Nucleoside and Nucleotide Analog Therapy

    American Journal of Transplantation

    Volume 11, Issue 3, March 2011, Pages: 511–517, S. Saab, S. Desai, D. Tsaoi, F. Durazo, S. Han, A. McClune, C. Holt, D. Farmer, L. Goldstein and R. W. Busuttil

    Version of Record online : 7 FEB 2011, DOI: 10.1111/j.1600-6143.2010.03416.x

  8. Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation

    Transplant Infectious Disease

    Volume 14, Issue 5, October 2012, Pages: 479–487, E. Cholongitas, T. Vasiliadis, N. Antoniadis, I. Goulis, V. Papanikolaou and E. Akriviadis

    Version of Record online : 25 MAY 2012, DOI: 10.1111/j.1399-3062.2012.00741.x

  9. You have free access to this content
    A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post–liver transplantation hepatitis B prophylaxis

    Hepatology

    Volume 48, Issue 5, November 2008, Pages: 1460–1466, Peter W. Angus, Scott J. Patterson, Simone I. Strasser, Geoffrey W. McCaughan and Edward Gane

    Version of Record online : 21 JUL 2008, DOI: 10.1002/hep.22524

  10. Evolving experience of hepatitis B virus prophylaxis in liver transplantation

    Transplant Infectious Disease

    Volume 4, Issue 3, September 2002, Pages: 137–143, M.R. Honaker, M.H. Shokouh-Amiri, S.R. Vera, R.R. Alloway, H.P. Grewal, K.L. Hardinger, A.T. Kizilisik, T. Bagous, J. Trofe, R.J. Stratta, M.F. Egidi and A.O. Gaber

    Version of Record online : 5 NOV 2002, DOI: 10.1034/j.1399-3062.2002.01012.x

  11. You have free access to this content
    Prevention of and Treatment for Hepatitis B Virus Infection After Liver Transplantation in the Nucleoside Analogues Era

    American Journal of Transplantation

    Volume 3, Issue 3, March 2003, Pages: 250–258, George V. Papatheodoridis, Vasilios Sevastianos and Andrew K. Burroughs

    Version of Record online : 3 MAR 2003, DOI: 10.1034/j.1600-6143.2003.00063.x

  12. Anti-hepatitis B surface immunoglobulin reduction in early postoperative period after liver transplantation in hepatitis B virus-positive patients

    Hepatology Research

    Volume 41, Issue 12, December 2011, Pages: 1189–1198, Masatoshi Ishigami, Yasuharu Onishi, Takashi Ito, Yoshiaki Katano, Akihiro Ito, Yoshiki Hirooka, Tetsuya Kiuchi and Hidemi Goto

    Version of Record online : 29 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00884.x

  13. You have free access to this content
    High Viremia, Prolonged Lamivudine Therapy and Recurrent Hepatocellular Carcinoma Predict Posttransplant Hepatitis B Recurrence

    American Journal of Transplantation

    Volume 10, Issue 7, July 2010, Pages: 1649–1659, J. Chun, W. Kim, B. G. Kim, K. L. Lee, K.-S. Suh, N.-J. Yi, K. U. Park, Y. J. Kim, J.-H. Yoon and H. S. Lee

    Version of Record online : 25 JUN 2010, DOI: 10.1111/j.1600-6143.2010.03162.x

  14. You have free access to this content
    Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review

    Liver Transplantation

    Volume 17, Issue 10, October 2011, Pages: 1176–1190, Evangelos Cholongitas, John Goulis, Evangelos Akriviadis and Geore V. Papatheodoridis

    Version of Record online : 26 SEP 2011, DOI: 10.1002/lt.22354

  15. You have free access to this content
    Prophylactic strategies for hepatitis B patients undergoing liver transplant: A cost-effectiveness analysis

    Liver Transplantation

    Volume 12, Issue 5, May 2006, Pages: 736–746, Yock Young Dan, Chun Tao Wai, Khay Guan Yeoh and Seng Gee Lim

    Version of Record online : 20 APR 2006, DOI: 10.1002/lt.20685

  16. You have free access to this content
    Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis

    Transplant International

    Volume 22, Issue 4, April 2009, Pages: 387–394, Wensheng Rao, Xuejie Wu and Dianrong Xiu

    Version of Record online : 7 NOV 2008, DOI: 10.1111/j.1432-2277.2008.00784.x

  17. You have free access to this content
    Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation

    Liver Transplantation

    Volume 18, Issue 5, May 2012, Pages: 514–523, Marie A. Laryea and Kymberly D. Watt

    Version of Record online : 22 APR 2012, DOI: 10.1002/lt.23408

  18. You have free access to this content
    Current management of hepatitis B virus infection before and after liver transplantation

    Liver International

    Volume 29, Issue 9, October 2009, Pages: 1294–1305, George V. Papatheodoridis, Evangelos Cholongitas, Athanasios J. Archimandritis and Andrew K. Burroughs

    Version of Record online : 10 JUL 2009, DOI: 10.1111/j.1478-3231.2009.02085.x

  19. You have free access to this content
    Liver transplantation for hepatitis B: What is the best hepatitis B immune globulin/antiviral regimen?

    Liver Transplantation

    Volume 14, Issue S2, October 2008, Pages: S15–S22, Peter W. Angus and Scott J. Patterson

    Version of Record online : 29 SEP 2008, DOI: 10.1002/lt.21614

  20. You have free access to this content
    Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation

    American Journal of Transplantation

    Volume 10, Issue 8, August 2010, Pages: 1823–1833, B. Degertekin, Steven-Huy B. Han, E. B. Keeffe, E. R. Schiff, V. A. Luketic, R. S. Brown, Jr., S. Emre, C. Soldevila-Pico, K. R. Reddy, M. B. Ishitani, T. T. Tran, T. L. Pruett, A. S. F. Lok and the NIH HBV-OLT Study Group

    Version of Record online : 23 MAR 2010, DOI: 10.1111/j.1600-6143.2010.03046.x